AIHTA - Publications - Search - Nivolumab (Opdivo®) as monotherapy for the adjuvant treatment of Stage IIB or IIC melanoma, or melanoma with involvement of lymph nodes or metastatic disease

Rothschedl, E. and Wolf, S. (2023): Nivolumab (Opdivo®) as monotherapy for the adjuvant treatment of Stage IIB or IIC melanoma, or melanoma with involvement of lymph nodes or metastatic disease. Fact Sheet Nr. 144.

[thumbnail of Fact Sheet Nr.144.pdf]
Preview
 PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
121kB

Item Type:Horizon Scanning of Medicines
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WR Dermatology
Language:English
Series Name:Fact Sheet Nr. 144
Deposited on:21 Aug 2023 14:43
Last Modified:21 Aug 2023 14:43

Repository Staff Only: item control page